| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Exec. VP, European Commercial
1 company
Daniell Richard is an Exec. VP, European Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD. Recent SEC Form 4 filings include 0 buys and 21 sells.
Estimated insider holdings value: $5.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Exec. VP, European Commercial | Sale+OE | 115,468 | $28.68 | $3,311,125.73 | -70.5% | +10.3% | - | |
| Mar 5, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Exec. VP, European Commercial | Sale+OE | 70,961 | $15.91 | $1,128,642.09 | -32.8% | +8.1% | +99.7% | |
| Mar 5, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Exec. VP, European Commercial | Sale+OE | 140,372 | $15.80 | $2,217,406.52 | -36.7% | +8.1% | +99.7% | |
| Mar 4, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Exec. VP, European Commercial | Sale+OE | 62,250 | $16.06 | $999,424.86 | -82.8% | +10.0% | +109.8% | |
| Aug 12, 2024 | TEVA Teva Pharmaceutical Industries Ltd | Exec. VP, European Commercial | Sell | 98,943 | $17.30 | $1,711,446.75 | -100% | +1.7% | -2.8% | |
| Mar 5, 2024 | TEVA Teva Pharmaceutical Industries Ltd | Exec. VP, European Commercial | Sale+OE | 48,629 | $13.52 | $657,240.39 | -22.4% | +25.4% | +17.4% | |
| Mar 4, 2024 | TEVA Teva Pharmaceutical Industries Ltd | Exec. VP, European Commercial | Sale+OE | 95,762 | $13.34 | $1,277,206.52 | -40.7% | +26.3% | +16.7% | |
| Feb 28, 2024 | TEVA Teva Pharmaceutical Industries Ltd | Exec. VP, European Commercial | Sale+OE | 20,599 | $13.12 | $270,176.48 | -22.8% | +28.0% | +24.7% | |
| Mar 7, 2023 | TEVA Teva Pharmaceutical Industries Ltd | Exec. VP, European Commercial | Sell | 72,009 | $9.55 | $687,948.66 | -27.1% | -23.6% | +43.3% | |
| Feb 28, 2023 | TEVA Teva Pharmaceutical Industries Ltd | Exec. VP, European Commercial | Sale+OE | 44,252 | $9.89 | $437,501.82 | -28.1% | -27.2% | +32.1% |